Harbour Antibodies' Series A Round

Harbour Antibodies raised a round of funding on July 24, 2013. Investors include Atlas Venture.

Harbour Antibodies is enabling the development of new therapeutic human monoclonal antibodies through the creation of two lines of transgenic mice. The H2L2 mice, which generate full IgG and the HCAb …

Articles about Harbour Antibodies' Series A Round: